VIRxSYS is a private biotechnology company using proprietary lentiviral vector delivery and RNA payload platforms to develop therapies for serious human diseases. The Company's initial lentiviral delivery technology was exclusively licensed from The Johns Hopkins University and has been substantially advanced in the Company's laboratories. The RNA payload technology was acquired and has been integrated with the Company's lentiviral delivery technology. In addition to preclinical programs for cardiovascular and genetics the Company is currently developing gene and vaccine therapies for HIV, one of which, VRX496, has advanced to Phase II human clinical trials.
View Top Employees from VIRxSYS Corporation| Website | http://www.virxsys.com |
| Revenue | $9 million |
| Employees | View employees |
| Founded | 1998 |
| Address | 200 Perry Pkwy, Ste 1A, Gaithersburg, Maryland 20877, US |
| Phone | (301) 987-0480 |
| Fax | (301) 987-0489 |
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Genetics, Health Care, Medical |
| Competitors | AGTC, Audentes Therapeutics, Ceregene , Inc., Introgen Therapeutics, Inc., VIVEbiotech |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular VIRxSYS Corporation employee's phone or email?
VIRxSYS Corporation Questions
The VIRxSYS Corporation annual revenue was $9 million in 2024.
VIRxSYS Corporation is based in Gaithersburg, Maryland.
The NAICS codes for VIRxSYS Corporation are [54, 5417, 541].
The SIC codes for VIRxSYS Corporation are [28, 283].
Related Companies
